A detailed history of Western Financial Corporation transactions in Abb Vie Inc. stock. As of the latest transaction made, Western Financial Corporation holds 6,342 shares of ABBV stock, worth $1.14 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
6,342
Previous 5,954 6.52%
Holding current value
$1.14 Million
Previous $912,000 6.69%
% of portfolio
0.6%
Previous 0.65%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

BUY
$134.21 - $153.93 $52,073 - $59,724
388 Added 6.52%
6,342 $851,000
Q2 2022

Jul 22, 2022

BUY
$137.62 - $174.96 $819,389 - $1.04 Million
5,954 New
5,954 $912,000
Q3 2021

Oct 22, 2021

SELL
$106.4 - $120.78 $212,161 - $240,835
-1,994 Closed
0 $0
Q2 2021

Jul 16, 2021

BUY
$105.21 - $117.21 $3,682 - $4,102
35 Added 1.79%
1,994 $225,000
Q4 2020

Feb 03, 2021

BUY
$80.49 - $108.67 $157,679 - $212,884
1,959 New
1,959 $209,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Western Financial Corporation Portfolio

Follow Western Financial Corporation and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Western Financial Corporation, based on Form 13F filings with the SEC.

News

Stay updated on Western Financial Corporation with notifications on news.